COMPANY PROFILE

TAE Life Sciences

Explore full profile

State-of-the-art medical technology enabling convenient clinical access to Boron Neutron Capture Therapy (BNCT)

Irvine, United StatesFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2020

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About TAE Life Sciences

TAE Life Sciences is at the forefront of cancer research, specializing in Boron Neutron Capture Therapy (BNCT), a cutting-edge, non-invasive cancer treatment. BNCT targets and destroys cancer cells while minimizing damage to surrounding healthy tissue. The company serves patients with the most challenging malignancies, offering new hope through advanced radiotherapy. Operating in the healthcare and biotechnology sectors, TAE Life Sciences combines expertise in particle accelerators and neutron technology to develop state-of-the-art neutron sources and targeted boron drugs. Their business model focuses on research and development, aiming to commercialize their proprietary BNCT technology. Revenue is anticipated from the eventual sale and licensing of their innovative treatment solutions.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Irvine, United States
Employees: 72
Open positions: 1
Dealroom signal: 47.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Radiotherapy, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Jun 2020	$30M	$120M	Artis Ventures	—
SERIES AOther financing	Mar 2018	$40M	$160M	Artis Ventures	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

TAE Life Sciences website traffic

Latest recorded traffic for TAE Life Sciences is 1.2K monthly website visits, down 33.3% over the last three months. TAE Life Sciences's team grew 4.3% over the past year.

Latest monthly visits1.2K 3-month web change-33.3% 1-year team growth+4.3%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Bioconjugations Chemist/BiochemistSanta Monica, CA · Other · Sep 5, 2026 Senior System Test EngineerIrvine, California, 92618, United States, Northern America, Americas · Backend Development · Aug 26, 2026 System Test EngineerIrvine, California, 92618, United States, Northern America, Americas · Backend Development · Aug 26, 2026 Field Service EngineerMilan, Lombardy, Italy · Other · Aug 16, 2026 Technical WriterIrvine, California, 92618, United States, Northern America, Americas · Backend Development · Aug 5, 2026

5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational	73	$3.9M	$15M
VIViewRayAdvanced radiation therapy technology for the treatment of cancer	Oakwood, United States	Operational
AOAomicsAomics is a pioneering healthcare research solutions company that advances patient care through cutting-edge immuno-oncology research	Eschborn, Germany	Operational
MYMYPLMYPL aims to develop patients and healthcare professionals empowerment, proposing an interactive web platform of communication	Montigny-le-Bretonneux, France	Operational
CYCytedUnique approach combines expertise in gastrointestinal oncology, digital pathology and AI-driven biomarker discovery	Cambridge, United Kingdom	Operational
MIMindPeakMindPeak automates visual diagnosis, making microscopical analysis more accessible to support in accurate cancer diagnoses	Hamburg, Germany	Operational
LILinkingmedLinkingmed is focused on establishing oncology data platform and medical data analysis	Dongcheng District, China	Operational
ONOncomedicsBiotechnology company that specializes in the research of personalized treatments against cancer	Limoges, France	Operational